One of the outpatient rehab options for individuals in Vancouver who are battling with opioid dependence and addiction is called opioid maintenance therapy. Licensed centers and doctors are authorized to give specific medications to opioid dependent individuals, many of which are opioids also and are addictive. With low enough doses the individual doesn't feel high but also doesn't have intense cravings and is not experiencing opioid withdrawal. Methadone is the first med tried for this reason, but there are other choices currently to pick from.
Methadone is an opiate and is meant to be taken at an out-patient medical center certified to dispense the med, which is taken daily in liquid or pill form. The price of the med is about $150 a month. Buprenorphine is also an opioid-based drug, and is a pill often taken every other day. But different from Methadone that can only be administered in highly structured medical centers, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is around $300.00 a month for the generic version of the drug. There is also a type of buprenorphine that contains the ingredient naloxone, which is a drug which reverses the effects of opiates. A person consuming this formulation, AKA Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and costs about $450 /month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other medications aforementioned it is an opioid blocker and isn't an opioid. There is an option to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 /month.
There are 3 Alcohol and Drug Rehab Centers offering this service in Vancouver, WA
For All Alcohol and Drug Rehabilitation Centers In Vancouver, Click Here.